| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药工业(元) | 949,175,340.36 | 2,356,740,078.27 | 1,111,801,833.06 |
| 医药商业(元) | 108,816,469.06 | 257,929,084.09 | 127,965,462.22 |
| 营业成本(元) | |||
| 医药工业(元) | 443,755,700.77 | 1,329,369,028.51 | 652,400,749.34 |
| 医药商业(元) | 80,208,639.13 | 185,251,373.58 | 91,988,132.87 |
| 毛利(元) | |||
| 医药工业(元) | 505,419,639.59 | 1,027,371,049.76 | 459,401,083.72 |
| 医药商业(元) | 28,607,829.93 | 72,677,710.51 | 35,977,329.35 |
| 毛利率(%) | |||
| 医药工业(%) | 53.25 | 43.59 | 41.32 |
| 医药商业(%) | 26.29 | 28.18 | 28.11 |
| 收入构成(%) | |||
| 医药工业(%) | 89.71 | 90.14 | 89.68 |
| 医药商业(%) | 10.29 | 9.86 | 10.32 |
| 毛利构成(%) | |||
| 医药工业(%) | 94.64 | 93.39 | 92.74 |
| 医药商业(%) | 5.36 | 6.61 | 7.26 |